Iovance Biotherapeutics (IOVA) Enterprise Value (2010 - 2026)
Iovance Biotherapeutics (IOVA) posted Enterprise Value of $1.59 billion for Q2 2026, up 453.0% from $286.92 million a year earlier and up 29.6% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Enterprise Value (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Enterprise Value at Iovance Biotherapeutics was $675.4 million; for FY2025, it came in at $827.61 million, down 57.2% from FY2024.
- In prior years, Iovance Biotherapeutics' Enterprise Value was $1.94 billion in FY2024 (+7.4%), $1.8 billion in FY2023 (+147.5%), $728.27 million in FY2022 (-70.8%) and $2.49 billion in FY2021.
- The Q2 2026 figure stands as the highest quarterly Enterprise Value since Q4 2024.
- On a year-over-year basis, Enterprise Value increased in four of the last eight quarters, with growth averaging 56.9%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q2 2026, with growth of 453.0%; the weakest was Q2 2025, with a decline of 86.7%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $1.22 billion (Q1 2026), $827.61 million (Q4 2025) and $535.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Iovance Biotherapeutics | 3.74 Bn | 2.45 Bn | 73.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.48 Bn |
| Jun 30, 2026 | 1.59 Bn |
| Mar 31, 2026 | 1.22 Bn |
| Dec 31, 2025 | 827.61 Mn |
| Sep 30, 2025 | 535.62 Mn |
| Jun 30, 2025 | 286.92 Mn |
| Mar 31, 2025 | 752.29 Mn |
| Dec 31, 2024 | 1.94 Bn |
| Sep 30, 2024 | 2.46 Bn |
| Jun 30, 2024 | 1.97 Bn |
| Mar 31, 2024 | 3.79 Bn |
| Dec 31, 2023 | 1.80 Bn |
| Sep 30, 2023 | 802.62 Mn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 744.54 Mn |
| Dec 31, 2022 | 728.27 Mn |
| Sep 30, 2022 | 1.15 Bn |
| Jun 30, 2022 | 1.32 Bn |
| Mar 31, 2022 | 2.13 Bn |
| Dec 31, 2021 | 2.49 Bn |
API Access
Iovance Biotherapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();